Ventilator-associated pneumonia (VAP) is the most common infection in intensive care units. It is caused by prolonged hospitalization and results in high mortality rates. This retrospective clinical study, of 140 patients in a surgical intensive care unit, aimed to identify the bacterial agents responsible for VAP infection, and determine antibiotic resistance rates in VAP. Antibiotic sensitivity was evaluated by culturing and testing tracheal aspirates from patients with clinical and radiological findings of VAP. The bacteria isolated most frequently were Pseudomonas aeruginosa (33.9%), Staphylococcus aureus (30.0%), Acinetobacter baumannii (26.1%), and Enterobacter species (4.3%). A. baumannii was more prevalent than in previous years. The results of antibiotic sensitivity testing suggested sulbactam/cefoperazone as the most appropriate drug for treating these patients. We suggest, however, that when staphylococcal pneumonia is suspected, a glycopeptide (vancomycin or teicoplanin) or combined trimethoprimsulfamethoxazole is used as first-line therapy until sensitivity results are obtained. In conclusion, development of antibiotic policies for individual hospitals can reduce high antibiotic resistance rates due to VAP.
Introduction
Nosocomial pneumonia is the most common infection occurring in intensive care units (ICUs), and increases mortality rates. In fact, nosocomial infections comprise approximately 15% of all hospital infections, and 40% of them are fatal. 1 Use of mechanical ventilation is the most important risk factor for nosocomial infection in the ICU: ventilator-associated pneumonia (VAP) is observed approximately 7 -20 times more frequently in adults who have undergone mechanical ventilation than in those who have not. 2, 3 The primary pathology of VAP and the general condition of a patient with this infection means it is not possible to wait the 48 h required for microbiological diagnosis before commencing treatment. 4, 5 Initial antibiotic therapy for VAP should, therefore, be empirical.
This study aimed to identify the bacterial agents responsible for VAP in our surgical ICU, and assess their antibiotic resistance rates.
Patients and methods
This was a retrospective study, so patient consent and ethical approval were not required.
PATIENTS
This study involved patients admitted to the surgical ICU of Gaziantep University Hospital between January 2001 and January 2003, who were diagnosed with VAP.
DIAGNOSIS
Patients with clinical and radiological evidence of lung infection within 48 h of initiation of mechanical ventilation were diagnosed with VAP. Signs of infection were: new infiltration on chest X-ray; highly purulent tracheobronchial secretion; fever (> 38.5°C) or hypothermia (< 36°C); leucocytosis or leucopenia; and decreased oxygen saturation.
SAMPLE COLLECTION
To characterize the pathogenic agents and evaluate the antibiotic sensitivity of the microorganisms, deep tracheal aspirates were taken. This sampling involved inserting a sterile aspiration catheter 30 cm into the trachea.
CULTURING TECHNIQUE
Two to 3 ml of deep tracheal aspirate were homogenized by vortex mixing, and 0.01 ml of the sample was used to inoculate sheep blood and eosin methylene blue (EMB) agar plates. Samples were incubated at 37°C for 24 h. Samples producing growth of ≥ 10 5 colony-forming units/ml were considered to contain VAP-causing agents. Bacteria were isolated from these colonies for further evaluation.
BACTERIAL IDENTIFICATION AND EVALUATION OF ANTIBIOTIC RESISTANCE
After initial testing (catalase, oxidase, Gram staining), bacteria were identified using standard methods and the Sceptor TM system (Becton Dickinson, NJ, USA). Minimum inhibitory concentration (MIC) values were determined from antimicrobial susceptibility tests, performed using the Sceptor TM system. Oxacillin disks were used to identify methicillin-resistant Staphylococcus strains. Any bacteria moderately susceptible to antibiotics were deemed resistant.
Results
A total of 230 strains associated with pneumonia were isolated from 140 patients with VAP: Of these 140 patients, 78 had one bacterial type only, 34 had two different bacteria, and 28 patients had three bacterial types. The bacteria identified and their frequencies are given in Table 1 .
Details of the antibiotic susceptibilities of the four most commonly isolated microorganisms are shown in Table 2 , in order of decreasing sensitivity.
It is worth noting that, compared with previous data (not shown), an increase in isolated A. baumannii strains was observed. The A. baumannii strains were highly resistant, with three strains deemed resistant to all antibiotics.
Amikacin resistance was not observed in any of the Enterobacter species strains. Methicillin sensitivity was found for 18% of the S. aureus strains (using oxacillin disks; Table 2 ), so the remaining S. aureus strains (82%) were methicillin resistant.
Discussion
Ventilator-associated pneumonia has been reported to occur in 9 -21% of patients undergoing ventilatory support due to 
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M Namiduru, G Güngör, I Karaoglan et al. Antibiotic resistance of bacterial ventilator-associated pneumonia respiratory deficiency; the mortality rate is 55 -71% in these individuals. 6 Clinical and microbiological discrimination of infection and colonization is, however, difficult in patients who have undergone mechanical ventilation.
In diagnosing VAP and identifying the aetiological agent, samples obtained via bronchoscopic methods such as protected brush specimen and bronchoalveolar lavage are preferred. However, when bronchoscopic methods cannot be performed routinely, tracheal aspirate sampling (which is a simpler and more economical method) can be used. 6, 7 One study found the results with these two techniques to be consistent in patients who had undergone mechanical ventilation and had a clinical diagnosis of pneumonia. 6 In our study of tracheal aspirate samples, Gram-negative bacteria were most prevalent in the samples from patients with VAP (70.0%), with P. aeruginosa the most frequently found species. These findings are similar to studies conducted elsewhere in Turkey. 8 P. aeruginosa is of worldwide importance as an agent of hospital-acquired infection, as it demonstrates multiple antibiotic resistance. 8, 9 When the antibiotic susceptibilities of P. aeruginosa strains isolated from our patients with VAP were analyzed, high rates of resistance to third generation cephalosporins, cefepime, aztreonam, gentamicin, ciprofloxacin and imipenem were observed. The rapid progress of resistance to imipenem, in particular, poses a major threat. From this we conclude that, in our surgical ICU, P. aeruginosa should be considered as a potential cause of pneumonia in patients with predisposing risk factors such as intubation and mechanical ventilation. Initial treatment should therefore be with sulbactam/cefoperazone or an anti-pseudomonal β-lactam with amikacin combination or levofloxacin.
An earlier study in our surgical ICU showed that A. baumannii was isolated from 15% of tracheal aspirate samples obtained from 1998 to 1999, and from 26.1% of aspirates in 2001. 10 The present study verified that the isolated A. baumannii strains exhibited multiple antibiotic resistance, and three of the 60 strains were resistant to all antibiotics. A high incidence of resistance to ampicillin/sulbactam, third generation cephalosporins, cefepime, aztreonam, and ciprofloxacin was also identified. However, the identified strains were susceptible to imipenem, sulbactam/ cefoperazone, levofloxacin (83.3%, 80% and 60%, respectively). Today, S. aureus is an important agent in nosocomial infection and communityacquired pneumonia, and methicillin resistance, which restricts the efficacy of β-lactam antibiotics, is becoming more prevalent in hospital isolates. 11 There are, thus, problems with therapy, as methicillinresistant strains could also be resistant to most other antibiotic groups. 11, 12 In our study, most strains of S. aureus were methicillin-resistant (81.16%; MRSA), while fewer were methicillin-susceptive (18.84%; MSSA). Teicoplanin or vancomycin are used to treat serious infections caused by MRSA, but in Turkey, resistance to teicoplanin has been reported in 14.3% of hospital-based MRSA strains; 13 vancomycin-resistant S. aureus strains have not yet been reported. Moreover, in our study it was remarkable that there were high numbers of S. aureus strains that were susceptible to trimethoprim/ sulfamethoxazole and piperacillin/tazobactam, although in similar studies the trimethoprim/ sulfamethoxazole susceptibility rates of S. aureus strains were reported to be as high as 82%, 65% and 75%. 5, 8, 14 In conclusion, if a diagnosis of VAP is made in a surgical ICU, pathogens such as P. aeruginosa, S. aureus and A. baumannii should be considered the likely cause until a microbiological diagnosis is obtained. Starting treatment with antibiotics or combinations that are effective against these pathogens may therefore prove to be a life-saving measure. 
